• English
    • français
  • Help
  •  | 
  • Contact
  •  | 
  • About
  •  | 
  • Login
  • HAL portal
  •  | 
  • Pages Pro
  • EN
  •  / 
  • FR
View Item 
  •   LillOA Home
  • Liste des unités
  • Protéomique, Réponse Inflammatoire, Spectrométrie de Masse (PRISM) - U1192
  • View Item
  •   LillOA Home
  • Liste des unités
  • Protéomique, Réponse Inflammatoire, Spectrométrie de Masse (PRISM) - U1192
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Design and synthesis of fungal-selective ...
  • BibTeX
  • CSV
  • Excel
  • RIS

Document type :
Article dans une revue scientifique: Article original
DOI :
10.1021/acs.jmedchem.9b00826
PMID :
31513387
Permalink :
http://hdl.handle.net/20.500.12210/74995
Title :
Design and synthesis of fungal-selective resorcylate aminopyrazole hsp90 inhibitors
Author(s) :
Huang, David [Auteur]
Leblanc, Emmanuelle [Auteur]
Shekhar-Guturja, Tanvi [Auteur]
Robbins, Nicole [Auteur]
Krysan, Damian [Auteur]
Pizarro, Juan Carlos [Auteur]
Whitesell, Luke [Auteur]
Cowen, Leah E. [Auteur]
Brown, Lauren E. [Auteur]
Journal title :
Journal of Medicinal Chemistry
Abbreviated title :
J. Med. Chem.
Publication date :
2019-09-12
ISSN :
1520-4804
HAL domain(s) :
Sciences du Vivant [q-bio]
English abstract : [en]
The molecular chaperone Hsp90, essential in all eukaryotes, plays a multifaceted role in promoting survival, virulence, and drug resistance across diverse pathogenic fungal species. The chaperone is also critically important, ...
Show more >
The molecular chaperone Hsp90, essential in all eukaryotes, plays a multifaceted role in promoting survival, virulence, and drug resistance across diverse pathogenic fungal species. The chaperone is also critically important, however, to the pathogen's human host, preventing the use of known clinical Hsp90 inhibitors in antifungal applications due to concomitant host toxicity issues. With the goal of developing Hsp90 inhibitors with acceptable therapeutic indices for the treatment of invasive fungal infections, we initiated a program to design and synthesize potent inhibitors with selective activity against fungal Hsp90 isoforms over their human counterparts. Building on our previously reported derivatization of resorcylate natural products to produce fungal-selective compounds, we have developed a series of synthetic aminopyrazole-substituted resorcylate amides with broad, potent, and fungal-selective Hsp90 inhibitory activity. Herein we describe the synthesis of this series, as well as biochemical structure-activity relationships driving selectivity for the Hsp90 isoforms expressed by Cryptococcus neoformans and Candida albicans, two pathogenic fungi of major clinical importance.Show less >
Language :
Anglais
Audience :
Internationale
Popular science :
Non
Administrative institution(s) :
INSERM
Université de Lille
Collections :
  • Protéomique, Réponse Inflammatoire, Spectrométrie de Masse (PRISM) - U1192
Submission date :
2022-06-15T13:57:46Z
Université de Lille

Mentions légales
Université de Lille © 2017